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Abstract 
The results presented in this paper allow for the estimation of the monthly UV exposure 
of the human facial region at various locations across the earth. The technique allows the 
graphical representation of the UV exposures over the face. The erythemal UV exposures 
as well as the vitamin D exposures to the human facial region have been investigated. 
The results gained in this paper, for clear sky and constant ozone indicate that the sun’s 
capability to promote the development of vitamin D in the human body does not follow 
the erythemal UV irradiances, in particular at high latitudes. For Amsterdam (52oN) in 
late winter, approximately 20% more UV is required to produce 215 J.m-2 of vitamin D 
weighted UV than erythemal UV.  
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Introduction 
Ultraviolet (UV) radiation’s interaction on human skin has both positive and negative 
effects. The positive effect includes an important component for the formation of vitamin 
D in the skin, whilst the negative includes the formation of skin cancers and premature 
skin photo-aging. The active form of vitamin D is technically referred to as 1,25 
hydroxyvitamin D (sometimes as calcitriol, or cholecalciferol). Sunlight interacts with the 
vitamin’s pre-cursor, 7-dehydrocholesterol to produce pre-vitamin D31. (Vitamin D will 
be used in this paper to denote this compound.)  
 
Vitamin D is also obtained from some foods, typically fortified milk. However, exposure 
to sunlight is considered the primary source of vitamin D, since the quantities of milk (the 
primary source other than sunlight) consumed in the U.S. is quite small2. In addition to 
the bone disease rickets, vitamin D has a suggested association with the development of 
various diseases, such as colon-rectal cancer, breast cancer, and type I diabetes. Recent 
research suggests that underexposure to UV radiation (hence Vitamin D production) is 
associated with premature cancer mortality in the American population3. 
 
The formation of non-melanoma skin cancers has been linked to exposure to solar UV 
with a higher incidence for people living in tropical and semi-tropical areas compared to 
those living further from the equator4. Research suggests that the sites of the lesions are 
coherent with the sites that receive high exposures to sunlight, for example, the head and 
neck in particular are likely to develop such lesions5. Previous research has calculated the 
ambient solar erythemal UV and UVA radiation on a horizontal plane at high and low 
latitudes in both the southern and northern hemispheres6. The research presented in this 
paper extends the previous research, as it allows the determination of erythemal UV 
exposures for the different latitudes to one of the highest UV exposure sites of the human 
body, namely, the face, for fairskinned populations. Additionally, this research compares 
the amount of UV radiation that is effective for the production of vitamin D at each of the 
low and high latitudes.  
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Materials & Methods 
Locations 
This study utilizes a previously developed UV radiation model to predict the biologically 
effective exposure on a horizontal plane7 and a technique to calculate the subsequent 
exposure received by the human face8. The relevant UV exposures to the facial region at 
four separate geographic sites were selected for comparison. The sites selected were 
Brisbane (27o S 153o E), Cairo (30o N 31.3o E), Amsterdam (52o N 5o E) and Ushuaia 
(54o S 68o W). These sites were selected as they represent urban regions and therefore 
have a high population density, are located at or close to sea level, and are approximately 
evenly distributed on either side of the equator. 
 
This study neglects the possible presence of cloud cover, altitude, and albedo contribution 
at these sites and the influence that these factors may have on the biologically effective 
horizontal plane UV and respective biologically effective UV exposure to the human 
face. Exposure levels calculated at each of these sites uses a nominal level of air, aerosol 
optical depth (AOD) and column ozone (320 DU) thickness, with the focus of this study 
being placed on geographical location, demonstrating the potential of the technique for 
assessing global scenarios. The standard ozone level of 320 DU was chosen as a first 
order approximation of the average ozone over these locations. Aerosol and air 
concentrations are based on the extinction coefficients and extinction amounts formulated 
primarily from the studies of Green et al9. Details of the model can be found in Appendix 
1. 
 
At each of the geographical sites selected, both the horizontal plane erythemal and 
vitamin D exposure is estimated for a single day in each month. Exposures are 
determined at sea level, which is a reasonable assumption given the locations of the 
selected sites. This analysis is performed so as to investigate the health outcomes 
associated with both excessive exposure to erythemally effective UV, and the possible 
insufficient production of vitamin D following under exposure to terrestrial levels of UV. 
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Furthermore, this study makes comparisons of the erythemally effective facial exposure 
at each of the geographical sites for a selected day in each season. In this way a 
"snapshot" of the likely facial exposures received in each of these regions will be 
provided for comparison. 
 
UV model 
The UV model employed to investigate the horizontal plane exposure is a developed 
hybrid of a number of semi-empirical UV transmittance equations and includes the 
variations in the earth-Sun distance. The model has been described previously7, although 
a number of new modifications have been made to account for variation in albedo and 
altitude above sea level (Appendix 1). For this research, altitude is normalised to sea level 
and albedo contribution is neglected. 
 
The UV model developed specifically for this research provides exposures that are on 
average within 10% of the horizontal plane daily erythemally effective exposures 
measured by the UV-Biometer (Solar Light Co. model 501) located at the University of 
Southern Queensland. A comparison of the modelled to measured daily erythemal UV 
irradiances, expressed in units of MED (minimum erythemal dose) for cloud free days, is 
shown in Figure 1. This accuracy may change depending on location and local 
atmospheric conditions. 
 
The model calculates the spectral UV irradiance (units of W/m2/nm) at 15 minute 
intervals across the entire biologically significant UV region, namely the 280 nm to 400 
nm region. The modelled output irradiance is weighted according to the erythema10 and 
vitamin D11 biological action spectra (shown in Figure 2). The vitamin D spectra is based 
on the conversion of 7-dehydrocholesterol to pre-vitamin D3 as measured at the four 
wavelengths of 296, 300, 306 and 316 nm.  The biologically effective irradiance is then 
integrated with respect to time and the position of the sun (15 minute intervals) to 
determine the effective daily erythemal and vitamin D exposure.  
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Facial Exposure Contouring 
This study includes a number of visual plots of the human facial region to highlight the 
potential of the developed model and how that model’s output can be used to plot 
exposure estimates over the complex facial topography. The technique used to determine 
the biologically effective facial exposure has been discussed previously7,8. Polysulphone 
dosimeters were utilized to determine the exposure to various facial locations. The 
polysulphone film used was constructed by the authors at the University of Southern 
Queensland, and has a response approximating that of the erythemal action spectrum. The 
thickness of the produced film is monitored, as increases in thickness of the film causes a 
change in spectral response which deviates from the erythemal action spectrum and can 
cause errors of up to 35% in the measured exposures12. 
 
To summarize,  polysulphone dosimeters were attached to a rotating human head manikin 
model and placed outdoors in an open, unshaded sports field in clear sky conditions. The 
radiometric uncertainty in the polysulphone measurements is of the order of ±10%. The 
nearest building was over 60 m away whilst the ground reflectivity of the grassy surface 
was estimated to be 5%. The method is detailed in Downs et al7. Briefly, the dosimeters 
were attached to the forehead, nose, left and right cheek, left and right ear, chin, front of 
the neck, left and right shoulders, and upper chest and measurements with these 
dosimeters were taken in solar zenith angle (SZA) ranges from 0° to 80° in 10° steps (no 
change in optical absorbency was recorded in the range 80o to 90o). The ratio of the UV 
exposure to a particular facial anatomical site compared to the exposure to a horizontal 
plane (known as the exposure ratio) was determined at each 10° interval. The modelled 
biologically effective horizontal plane UV (in 10o intervals) for each location was 
weighted with the appropriate SZA facial exposure ratio (for SZA’s above 80o the 70o to 
80o exposure ratio was used) for the appropriate anatomical site. These values were 
summed from 6:00 am to 6:00 pm to produce daily facial exposure estimates for the 
different facial sites. A series of contour plots over the facial region were drawn by 
bilinearly interpolating the exposures between each of the dosimeter sites over the entire 
facial region. The analysis of the exposure ratios and production of the contour plots was 
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handled using IDL: Interactive Data language (Research Systems, Inc., IDL version 
5.3.1). 
 
The model technique was used to determine the daily facial erythemal exposure for the 
first day of each season for Brisbane and Amsterdam using the assumption that no hat or 
sunscreen was employed and that the head was in an upright position. These two sites 
were selected for the comparison of facial exposure distributions as they exhibit the 
greatest seasonal contrast observable between the mid and high latitudes. Estimates of the 
erythemal facial exposure are made under clear sky conditions. 
 
Results and Discussion 
The estimated horizontal plane erythema and vitamin D response, for fair skinned people, 
at each of the four selected sites is shown in Table 1. Early represents the first day of 
each season, followed by the mid seasonal daily exposure of the season, and late refers to 
the last day of each season. Exposures listed are expressed relative to 215 J/m2 of the 
effective biological exposure, which for erythema, approximates 1 MED. The table lists 
the effective daily exposures for the first day of each month within each respective season 
(both hemispheres). Exposure of an individual’s whole body to one MED of sunlight is 
equivalent to ingesting about 250 µg (10,000 IU) of vitamin D13. Exposure to 1 MED of 
sunlight is 17 to 50 times the recommended adequate intake (AI) for vitamin D from 
dietary sources14. Therefore, for an older woman to obtain the equivalent of 15 µg (600 
IU) of vitamin D per day (AI for women > 70 years of age), she would need to expose 
6% of her body surface (hands, face, forearms) to sunlight for 15 to 30 minutes two or 
three times a week13.  
 
Figure 3 provides a comparison between the daily erythema and vitamin D response at 
each of the four sites for the first day of each month in a given year for a horizontal plane. 
This figure illustrates the difference between sites located at low and high latitudes, and 
how this affects the relative production of vitamin D. As expected there is little difference 
in the effective exposure between sites of approximately the same latitude and 
considerable contrast between sites of different latitudes. Of significant interest is the 
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relative production of vitamin D. Sites at low latitudes always receive sufficient sunlight 
to sustain consistently higher levels of vitamin D compared to effective erythemal 
exposures, while sites at high latitudes experience a “cross-over” in winter whereby the 
effective erythemal exposure exceeds the biologically effective vitamin D. The reduced 
effectiveness of the skin to produce vitamin D when the sun is lower towards the horizon 
has been noted before11. In the winter months at Amsterdam and Ushuaia, the amount of 
biologically effective UV for vitamin D production is less than that for erythema. This 
data shows that the health concerns associated with the insufficient production of vitamin 
D, such as the incidence of diseases such as rickets for example, are more likely to 
develop in locations where solar UV levels are low for much of the year and particularly 
in locations where populations tend to spend a lot of time indoors and out of direct 
sunlight. However, as is well known, there are also negatives associated with spending 
too much time in the sun, and Table 1 shows the possibility of the risk of over exposure 
to erythemal UV, particularly at low latitudes.  
 
The lower relative production of vitamin D for the winter months at high latitudes is due 
to the weighting of the vitamin D action spectrum where the effective production of 
vitamin D is more dependent on the shorter wavelengths than the effective erythemal 
response. The low solar elevations and subsequently increased path through the 
atmosphere result in increased absorption and scattering of the shorter wavelengths. The 
relative proportions of absorption and scattering are both more pronounced at the shorter 
wavelengths due to increased absorption by ozone and increased Rayleigh scattering at 
the shorter wavelengths. Consequently, at these higher latitudes, the production of 
vitamin D due to UV falling on the skin tends to be lower than the effective erythemal 
response due to the reduced relative irradiances of the shorter wavelengths. In 
comparison, at lower latitudes, where the sun is able to reach high solar elevations, the 
relative production of vitamin D tends to be higher, due to reduced scattering and 
absorption of the more effective shorter wavelengths. 
 
When dealing with health concerns due to over exposure caused by terrestrial UV, it is 
convenient to examine the anatomical distribution of the UV exposure. Figure 4 makes a 
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comparison between the erythemal facial exposure of a subject exposed for an entire day 
to the levels listed in Table 1 for the mid months of each season.  
 
While the developed model can be used as an effective tool to examine the UV variation 
in the horizontal plane, it is useful for examining the facial distribution of exposure with 
respect to the epidemiology of cancerous lesions and familiar erythemal reactions. Figure 
4 shows a marked contrast between a subject located in Amsterdam and one located in 
Brisbane. A mid summer exposure in Amsterdam, looks similar to that of a Brisbane 
spring time exposure, while the mid summer exposure in Brisbane indicates clearly the 
heightened risk of a much more severe sunburn over most of the face. It is interesting to 
note in all eight plots of Figure 4, that for an unprotected facial region, after the vertex of 
the head, the nose is the most likely location of the face to receive the highest facial 
exposure. In a similar fashion, the biologically effective exposures for vitamin D 
production may also be shown in the same graphical manner. 
 
These predicted results are consistent with measured facial exposure data of other 
researchers15,16. Included with each plot of the figure is the horizontal plane exposure 
received in each 10o range recorded over the course of a day. Facial exposures are 
influenced the most by exposures received during the middle of the day, with high solar 
elevations having the greatest effect on horizontal facial topography such as the vertex of 
the head and the nose. The effective distribution of exposure is thus more likely to affect 
these areas of the face when the sun reaches high solar elevations at low latitudes, 
however at high latitudes, low solar elevations reduce the vertical component of the direct 
UV that reaches the face and so broader facial exposure distributions are received. Such 
results may indicate an increased incidence of cancerous lesions across a broader facial 
range at progressively high latitudes, although at a much lower incidence than at low 
latitudes.   
 
Conclusions 
The results presented in this paper allow for the estimation of the monthly UV exposure 
of the human facial region at various locations across the earth. The authors investigated 
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the erythemal UV exposures as well as the vitamin D exposures. The vitamin D 
exposures are an important tool for the estimation of the sun’s ability to produce vitamin 
D in the human body. For some of the cold, northern locations, the facial region may be 
the only area of the body with skin exposed to sunlight, and hence vitamin D production 
capability. The results presented in Figure 3 highlight the need for understanding of the 
physical environment at high latitudes and its effect on vitamin D formation.  
 
For both the Ushuaia and Amsterdam locations, the capability of the sun to produce 
vitamin D is diminished in the winter months. For Amsterdam in late winter, 
approximately 20% more UV is required to produce 215 J.m-2 of vitamin D weighted UV 
than erythemal UV. The higher relative proportion of absorption and scattering at the 
shorter UV wavelengths at these high latitudes alters the amount of UV required to 
produce vitamin D. These results neglect the influence of facial skin type and individual 
variations in the skin. The model also neglects to consider the position of the subject with 
respect to the environment, variation in the atmospheric conditions, and variations in the 
physical environment that inevitably change throughout the year.  
 
This paper has extended the previous research to allow the determination of the UV 
exposures to the human facial region for the different latitudes. In this case, the results 
were shown graphically for the erythemal UV exposures, however the technique allows 
the graphical representation of the UV exposures over the face for the vitamin D 
production or for any other biological process and highlights the need for further research 
in this area. 
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Appendix 1 
Specifically the model determines both the direct and diffuse components of the UV irradiance. In this latest version of the developed 
hybrid, the equations are arranged as follows whereby (1) represents the direct irradiance9 and (2) the diffuse17  
 
tA
dir eHyB
−= )(),,( λμθλ    …(1) 
 
In equation (1), ),,( yBdir θλ  is the local ground level direct spectral irradiance at a given wavelength, solar zenith angle, and altitude, 
 is the attenuating thickness of the atmosphere along the path of the direct solar beam, tA )(λH  is the extra-terrestrial spectral 
irradiance, and μ  is the cosine response, )cos(θ  that describes the direct solar irradiance falling vertically on a horizontal plane. 
 
And, ∑= j
j
j
tA μ
τ
 
 
Where 321 ,, τττ  are the resultant product of the wavelength dependent species optical depth and altitude dependent concentrations of 
air, ozone and aerosols respectively, and 321 ,, μμμ are geometric cosine functions that describe each of the aforementioned species 
relative to a spherical earth. 
And, 
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321 ,, ttt  are constants that depend on the altitude distributions of air, ozone, and aerosol species. 
d
D
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255.1=apK  at sea level, 32.12 =q  at sea level, 62.1=ozK , 40.2=κ , 48.7=δ , 10.11 =q , 148.1=q , and 4=p  
 
and at altitude,  ))538.0(0487.0179.01(872.0 2−++= pap yK τ
)106.01(06.12 yq +=  
 
Here y is the altitude above sea level expressed in kilometres, and pτ  is a wavelength and altitude dependent atmospheric parameter 
(product of the aerosol optical depth and aerosol species concentration). 
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 And, ud SrA )(λ=  
uS is the upward irradiance resulting from the local surface albedo, and )(λr is the air reflectivity function describing the spectral 
reflectivity of the above atmosphere such that Ad is the total downward albedo contribution of the diffuse irradiance resulting from 
downward atmospheric backscatter. The formulation of )(λr is that used by Ruundel17 and given by Schippnick and Green18 p. 96 
equations (28) and (29). 
Furthermore, 
g
dsg
u Ar
EGA
S
)(1 λ−=  
Where Ag is the surface albedo measured as a percentage, Gs is the global ultraviolet irradiance measured at sea level without an 
albedo contribution and, Ed is the normalised altitude dependence defined as the ratio of the albedo contribution at altitude to the 
albedo contribution at sea level. 
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Table 1 – Daily erythemal and vitamin D effective exposures on a horizontal plane expressed relative to 215 J m-2.  
 Brisbane Cairo Ushuaia Amsterdam 
 Erythema Vitamin D Erythema Vitamin D Erythema Vitamin D Erythema Vitamin D 
Season / 215Jm-2 / 215Jm-2 / 215Jm-2 / 215Jm-2 / 215Jm-2 / 215Jm-2 / 215Jm-2 / 215Jm-2
Early  30.7 58.0 29.0 54.6 21.3 38.4 22.0 39.8
Summer 31.2 59.0 29.2 55.2 22.4 40.6 22.8 41.6
Late 29.3 55.1 27.5 51.8 17.2 30.3 18.8 33.6
         
Early  24.6 45.8 23.1 42.8 10.0 16.2 11.7 19.4
Autumn 17.2 30.9 16.5 29.6 3.6 4.6 5.2 7.2
Late 10.7 18.0 9.9 16.4 1.0 0.8 1.5 1.5
         
Early  6.9 10.7 6.2 9.3 0.3 0.2 0.5 0.3
Winter 6.3 9.6 5.6 8.2 0.3 0.1 0.4 0.2
Late 8.7 14.1 8.3 13.3 0.6 0.4 1.0 0.8
         
Early  14.2 25.0 13.7 23.8 2.3 2.5 3.3 4.0
Spring 21.3 39.2 21.0 38.5 7.0 10.6 9.1 14.4
Late 27.6 51.8 26.4 49.4 14.9 25.6 16.4 28.7
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FIGURE CAPTIONS 
 
Figure 1: Comparison of the modelled to measured erythemal exposures. 
 
Figure 2: Erythemal Action Spectrum and Vitamin D spectrum 
 
Figure 3: Comparison of the daily erythemal and vitamin D exposure plotted for the first day of each month.  
 
Figure 4a: Seasonal erythemal exposure in Brisbane. 
 
Figure 4b: Seasonal erythemal exposure in Amsterdam. 
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Figure 1: Comparison of the modelled to measured erythemal exposures. 
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Figure 2 – Erythemal Action Spectrum and Vitamin D Spectrum  
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Figure 3: Comparison of the daily erythemal and vitamin D exposure plotted for the first day of each month.  
Brisbane Cairo 
Erythema and Vitamin D3 response modelled for Brisbane
0.1
1
10
100
J
a
n
u
a
r
y
F
e
b
r
u
a
r
y
M
a
r
c
h
A
p
r
i
l
M
a
y
J
u
n
e
J
u
l
y
A
u
g
u
s
t
S
e
p
t
e
m
b
e
r
O
c
t
o
b
e
r
N
o
v
e
m
b
e
r
D
e
c
e
m
b
e
r
Month
D
a
i
l
y
 
B
i
o
l
o
g
i
c
a
l
 
r
e
s
p
o
n
s
e
 
(
2
1
5
 
J
/
m
2
)
Erythema
Vitamin D3
Erythema and Vitamin D3 response modelled for Cario
0.1
1
10
100
J
a
n
u
a
r
y
F
e
b
r
u
a
r
y
M
a
r
c
h
A
p
r
i
l
M
a
y
J
u
n
e
J
u
l
y
A
u
g
u
s
t
S
e
p
t
e
m
b
e
r
O
c
t
o
b
e
r
N
o
v
e
m
b
e
r
D
e
c
e
m
b
e
r
Month
D
a
i
l
y
 
B
i
o
l
o
g
i
c
a
l
 
r
e
s
p
o
n
s
e
 
(
2
1
5
J
/
m
2
)
Erythema
Vitamin D3
Ushuaia Amsterdam 
Erythema and Vitamin D3 response modelled for Ushuaia
0.1
1
10
100
J
a
n
u
a
r
y
F
e
b
r
u
a
r
y
M
a
r
c
h
A
p
r
i
l
M
a
y
J
u
n
e
J
u
l
y
A
u
g
u
s
t
S
e
p
t
e
m
b
e
r
O
c
t
o
b
e
r
N
o
v
e
m
b
e
r
D
e
c
e
m
b
e
r
Month
D
a
i
l
y
 
B
i
o
l
o
g
i
c
a
l
 
r
e
s
p
o
n
s
e
 
(
2
1
5
J
/
m
2
)
Erythema
Vitamin D3
 Erythema and Vitamin D3 response modelled for Amsterdam
0.1
1
10
100
J
a
n
u
a
r
y
F
e
b
r
u
a
r
y
M
a
r
c
h
A
p
r
i
l
M
a
y
J
u
n
e
J
u
l
y
A
u
g
u
s
t
S
e
p
t
e
m
b
e
r
O
c
t
o
b
e
r
N
o
v
e
m
b
e
r
D
e
c
e
m
b
e
r
Month
D
a
i
l
y
 
B
i
o
l
o
g
i
c
a
l
 
r
e
s
p
o
n
s
e
 
(
2
1
5
J
/
m
2
)
Erythema
Vitamin D3
 20
Figure 4a: Seasonal erythemal exposure in Brisbane. 
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Figure 4b: Seasonal erythemal exposure in Amsterdam. 
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